NervGen Pharma Corp. (NGEN)
2.19
0.00 (0.00%)
USD |
NASDAQ |
Sep 14, 16:00
2.19
0.00 (0.00%)
After-Hours: 16:31
NervGen Pharma Price : 2.19 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 2.17 | 2.23 | 2.14 | 2.185 | 559124.0 |
| Sep 10, 2026 | 2.10 | 2.165 | 2.07 | 2.16 | 313867.0 |
| Sep 09, 2026 | 2.19 | 2.27 | 2.115 | 2.13 | 366095.0 |
| Sep 08, 2026 | 2.32 | 2.345 | 2.16 | 2.19 | 713758.0 |
| Sep 04, 2026 | 2.31 | 2.395 | 2.275 | 2.33 | 920546.0 |
| Sep 03, 2026 | 2.34 | 2.36 | 2.275 | 2.32 | 434342.0 |
| Sep 02, 2026 | 2.32 | 2.36 | 2.31 | 2.33 | 383487.0 |
| Sep 01, 2026 | 2.21 | 2.37 | 2.100 | 2.32 | 1.058M |
| Aug 31, 2026 | 2.27 | 2.30 | 2.13 | 2.21 | 798260.0 |
| Aug 28, 2026 | 2.34 | 2.40 | 2.245 | 2.28 | 869261.0 |
| Aug 27, 2026 | 2.19 | 2.39 | 2.125 | 2.335 | 981778.0 |
| Aug 26, 2026 | 2.09 | 2.22 | 2.00 | 2.21 | 469101.0 |
| Aug 25, 2026 | 1.98 | 2.105 | 1.96 | 2.08 | 911367.0 |
| Aug 24, 2026 | 1.96 | 2.00 | 1.82 | 2.00 | 1.108M |
| Aug 21, 2026 | 1.78 | 1.86 | 1.727 | 1.86 | 542033.0 |
| Aug 20, 2026 | 1.75 | 1.77 | 1.684 | 1.76 | 253319.0 |
| Aug 19, 2026 | 1.68 | 1.775 | 1.68 | 1.75 | 493132.0 |
| Aug 18, 2026 | 1.68 | 1.72 | 1.63 | 1.71 | 378410.0 |
| Aug 17, 2026 | 1.68 | 1.695 | 1.63 | 1.68 | 501908.0 |
| Aug 14, 2026 | 1.78 | 1.78 | 1.655 | 1.735 | 562864.0 |
| Aug 13, 2026 | 1.77 | 1.82 | 1.733 | 1.76 | 553044.0 |
| Aug 12, 2026 | 1.75 | 1.79 | 1.725 | 1.76 | 387016.0 |
| Aug 11, 2026 | 1.71 | 1.76 | 1.71 | 1.74 | 202208.0 |
| Aug 10, 2026 | 1.73 | 1.74 | 1.695 | 1.70 | 354424.0 |
| Aug 07, 2026 | 1.73 | 1.747 | 1.68 | 1.71 | 278108.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InMed Pharmaceuticals, Inc. | 1.305 |
| Milestone Pharmaceuticals, Inc. | 0.9505 |
| Clearmind Medicine, Inc. | 0.92 |
| Lexaria Bioscience Corp. | 3.51 |
| Target Group, Inc. (Canada) | 0.0011 |
Price Related Metrics
| PEG Ratio | -0.0425 |
| Price to Book Value | 19.14 |
| Earnings Yield | -24.47% |
| Market Cap | 233.04M |
| PEGY Ratio | -0.0425 |